In the future study, more attention should be paid to identify regulatory mechanisms of ErbB4-PI3K/Akt-mTOR-Eif4ebp1 or ErbB4-PI3K/Akt-P27 pathways and the potential role of ET-1 in the treatment of ALS. Here, ERBB4 is linked to amyotrophic lateral sclerosis.